Ignite Creation Date:
2024-05-06 @ 1:50 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04146571
Status:
AVAILABLE
Last Update Posted:
2022-10-20
First Post:
2019-10-28
Brief Title:
Expanded Access to Ensartinib for Participants With ALK NSCLC
Sponsor:
Xcovery Holdings Inc
Organization:
Xcovery Holdings Inc
Organization Data
Organization:
Xcovery Holdings Inc
Class:
INDUSTRY
Study ID:
X396-CLI-205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Xcovery Holdings Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None